Recombinant human mannose-binding lectin (NatImmune/Enzon)

N/A

Report date: 2024/11/20 14:15:23

Base Information

Drug NameRecombinant human mannose-binding lectin (NatImmune/Enzon)
Drug Alias NamerhMBLrhMBL - NatImmune/Enzon
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionMannose-binding protein C stimulants
TargetsMannose-binding protein C
Therapy Area/IndicationsSolid tumoursHot FlashesFever +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNatimmune A/S
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEnzon Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursHot FlashesFever +[12] 

Other Information

ATC CodeN/A
Related LinksN/A